Board Member Dr. Karen Smith to serve as Interim Chief Medical Officer PHILADELPHIA, May 05, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a ...
In this Tribeca premiere, documentarian Jordan Bryon chronicles the dangers of embedding with a Taliban unit while undergoing his gender transition. By Lovia Gyarkye Arts & Culture Critic In the ...
PHILADELPHIA, May 05, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today ...